IAA
GPCR icon

Independent Advisor Alliance’s Structure Therapeutics GPCR Stock Holding History

Independent Advisor Alliance’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$244K Sell
4,543
-2,901
-39% -$128K 0.01% 904
2026
Q1 		$359K Buy
7,444
+2,901
+64% +$199K ﹤0.01% 1252
2025
Q4 		$316K Buy
+4,543
New +$185K 0.01% 781

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Independent Advisor Alliance's GPCR Position: Q2 2026 in Review

Independent Advisor Alliance reduced its Structure Therapeutics (GPCR) stake by 39% in Q2 2026, selling an estimated $128K and leaving 4,543 shares worth $244K. The position accounts for 0.01% of the portfolio, ranked #904.

Independent Advisor Alliance first reported a position in GPCR in Q4 2025 and has held it in 3 quarters since. The position peaked at $359K in Q1 2026. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Independent Advisor Alliance held 4,543 shares of Structure Therapeutics worth $244K as of Q2 2026.
  • Independent Advisor Alliance sold 2,901 Structure Therapeutics shares in Q2 2026, an estimated $128K.
  • Structure Therapeutics made up 0.01% of Independent Advisor Alliance's portfolio in Q2 2026, its #904 holding.
  • Independent Advisor Alliance first reported a position in Structure Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Independent Advisor Alliance's Structure Therapeutics position peaked at $359K in Q1 2026.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Independent Advisor Alliance's 13F filing for Q2 2026, filed 12 Aug 2026.